This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Value Investors Buy Premier (PINC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Income Stocks to Buy for December 19th
by Zacks Equity Research
WTBA, PINC and FG made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 19, 2024.
New Strong Buy Stocks for December 19th
by Zacks Equity Research
MNDY, WTBA, NJR, PINC and PLAB have been added to the Zacks Rank #1 (Strong Buy) List on December 19, 2024.
New Strong Buy Stocks for December 11th
by Zacks Equity Research
PINC, DXPE, PFIS, CBAN and APAM have been added to the Zacks Rank #1 (Strong Buy) List on December 11, 2024.
Best Income Stocks to Buy for December 11th
by Zacks Equity Research
PFIS, PINC and CBAN made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 11, 2024.
Best Value Stocks to Buy for December 11th
by Zacks Equity Research
PINC, DXPE and DFH made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 11, 2024.
New Strong Buy Stocks for December 9th
by Zacks Equity Research
PINC, MRVL, NTRS, MNDY and NBBK have been added to the Zacks Rank #1 (Strong Buy) List on December 9, 2024.
Best Value Stocks to Buy for December 9th
by Zacks Equity Research
PINC, PRIM and DXPE made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 9, 2024.
Best Income Stocks to Buy for December 9th
by Zacks Equity Research
PINC made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 9, 2024.
Are Investors Undervaluing Premier (PINC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Premier, Inc. (PINC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Premier (PINC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Best Income Stocks to Buy for November 25th
by Zacks Equity Research
DGICA, WTBA and PINC made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 25, 2024.
Best Value Stocks to Buy for November 25th
by Zacks Equity Research
PINC, SCHL and DGICA made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 25, 2024.
Is Premier (PINC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Income Stocks to Buy for November 13th
by Zacks Equity Research
MNR and PINC made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 13, 2024.
Here's What Key Metrics Tell Us About Premier (PINC) Q1 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Premier (PINC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Premier, Inc. (PINC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Premier (PINC) delivered earnings and revenue surprises of 30.77% and 7.79%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Premier (PINC) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Premier (PINC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Premier, Inc. (PINC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Premier (PINC) delivered earnings and revenue surprises of 40.82% and 12.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Premier (PINC) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Premier (PINC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
ReWalk Robotics (LFWD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
ReWalk (LFWD) delivered earnings and revenue surprises of 5.66% and 0.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
The Oncology Institute (TOI) delivered earnings and revenue surprises of -70% and 4.58%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Taysha Gene Therapies (TSHA) delivered earnings and revenue surprises of 10% and 69.28%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?